Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objectives: We investigated serum brain‐derived neurotrophin factor (BDNF), nerve growth factor (NGF), neurotrophin‐3 (NTF3), neurotrophin‐4 (NTF4) and the glial‐derived neurotrophic factor (GDNF), in relation to ketamine efficacy, in bipolar depressed patients resistant to treatment with antidepressants. Methods: Twenty‐five patients (4 male, 21 female), aged 27–67 years, with bipolar depression, receiving mood‐stabilizing medications, were studied. Antidepressants were discontinued for at least 7 days before single intravenous ketamine infusion (0.5 mg/kg body weight). Response to ketamine was defined as ≥50% reduction on 17‐item Hamilton Depression Rating Scale (HDRS) after 1 week, and remission as HDRS score ≤7. Serum BDNF, NGF, NTF3, NTF4 and GDNF levels were estimated by enzyme‐linked immunosorbent assay. Results: There were 13 ketamine responders and 12 non‐responders. The remission was obtained in eight and 12 patients after seven and 14 days, respectively. At baseline, there were no differences between responders and non‐responders in any of the neurotrophins. Serum BDNF was significantly reduced after 7 days in non‐responders. Serum NGF, NT3, NT4 and GDNF did not significantly change. Conclusions: The results confirm an antidepressant effect of ketamine infusion as an add‐on to mood‐stabilizing drugs in bipolar depression resistant to antidepressant treatment. They may also suggest a possible involvement of BDNF in this effect. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 1×
“Recently, Autry et al. (2011), in the mouse model, demonstrated that ketamine-mediated blockade of N-methyl-D-aspartic acid receptors causes de-suppression of translation of BDNF.”
BackgroundDiazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963 · cited 3×
“The results of our study corroborate those of American researchers (Diazgranados et al., 2010; Covvey et al., 2012; Zarate et al., 2012) showing that single ketamine infusion exerts a rapid antidepressant effect in depressive patients resistant to antidepressants, also in those with bipolar depression receiving mood-s…”
BackgroundResultZarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811 · cited 1×
“The results of our study corroborate those of American researchers (Diazgranados et al., 2010; Covvey et al., 2012; Zarate et al., 2012) showing that single ketamine infusion exerts a rapid antidepressant effect in depressive patients resistant to antidepressants, also in those with bipolar…”
ResultPrice, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600 · cited 1×
“Price et al. (2009), after infusion of ketamine, observed a reduction of suicidal thoughts and intentions in depressive patients.”
BackgroundMolendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Kenis, G., Prickaerts, J., Voshaar, R. O., & Elzinga, B. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.98 · Cited by 437 · cited 1×
“Also, a contribution of former treatment with antidepressant drugs to the baseline status of neurotrophins should not be neglected because treatment with antidepressants, especially with selective serotonin reuptake inhibitors, may also increase serum BDNF levels (Molendijk et al., 2011).”
BackgroundMachado-Vieira, R., Yuan, P., Brutsche, N., DiazGranados, N., Luckenbaugh, D., Manji, H. K., & Zarate, C. A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04659 · Cited by 155
Cited by
Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-053013-062946 · Cited by 422
“However, following treatment, serum levels of BDNF were significantly reduced in nonresponders (77).”
BackgroundFernandes, B. S., Molendijk, M. L., Köhler, C. A., Soares, J. C., Leite, C. M. G. S., Machado-Vieira, R., Ribeiro, T. L., Silva, J. C., Sales, P. M. G., Quevedo, J., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0529-7 · Cited by 291
“Of the studies considering BDNF changes with treatment for an index acute depressive episode, three provided data for responders [57, 67, 78], as defined by a decrease of at least 50 % in mean HDRS scores, and four for non-responders [56, 78, 89, 90].”
BackgroundInfluentialAntidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Browne, C. A., & Lucki, I. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00161 · Cited by 285
The use of ketamine as an antidepressant: a systematic review and meta‐analysis
Coyle, C. M., & Laws, K. R. (2015) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2475 · Cited by 279
The role of ketamine in treatment-resistant depression: A systematic review
Serafini, G., Howland, R., Rovedi, F., Girardi, P., & Amore, M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140619204251 · Cited by 234
“To date, there are only evidence [52,60,79-81] suggesting the antidepressant effect of ketamine infusion as add-on treatment to mood-stabilizing drugs in bipolar depression and in those severe forms of bipolar depression that are treatment-resistant to common antidepressant medications.”
Metadata
- Authors
- Rybakowski, J. K., Permoda‐Osip, A., Skibinska, M., Adamski, R., & Bartkowska‐Sniatkowska, A.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2012-11-05
- Volume
- 28
- Issue
- 1
- Pages
- 87-90
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W1957683846
- Cited by
- 93
- References
- 7
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved? https://app.cochat.ai/papers/10.1002/hup.2271
- The paper
- Rybakowski, J. K., Permoda‐Osip, A., Skibinska, M., Adamski, R., & Bartkowska‐Sniatkowska, A. (2013). Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved? Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2271
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.